Since 1999 MSF works in the hospital of the Chiradzulu district, taking care of opportunistic diseases linked with HIV and to prevent mother to child transmission of the HIV virus. Since August 2001, HIV/AIDS patients are treated with ARVs. Today, over 3000 patients are following this treatment., 2004, Malawi.
Report |

Untangling the Web of Antiretroviral Price Reductions 6th Edition

HIV/AIDS INTELLECTUAL PROPERTY AND TRADE
AIDS_report_UTW6_ENG_2004.pdf
Photograph by Gueorgui Pinkhassov

The data in this guide on ARV prices offered by originator companies and some generic companies in low- and middle-income countries are meant to provide potential buyers with clear and verified data.

This information is intended for use by government and non-profit procurement agencies, as well as other bulk purchasers of ARVs, including health facilities and nongovernmental organisations (NGOs).

This is the sixth edition of Untangling the Web of Price Reductions: A pricing guide for the purchase of ARVs for developing countries. The first edition was published in October 2001. The lack of clear information on pharmaceutical prices on the international market is a significant barrier to improving access to essential medicines in developing countries. The situation is particularly complex in the case of antiretrovirals (ARVs).

Additional publications in the Untangling the Web report series are available here.

Learn more about MSF’s work to improve access to lifesaving HIV treatment.